These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease. Hinterleitner TA; Petritsch W; Aichbichler B; Fickert P; Ranner G; Krejs GJ Z Gastroenterol; 1997 Aug; 35(8):603-8. PubMed ID: 9297775 [TBL] [Abstract][Full Text] [Related]
26. The absorption and conjugation of methyldopa in patients with coeliac and Crohn's diseases during treatment. Renwick AG; Higgins V; Powers K; Smith CL; George CF Br J Clin Pharmacol; 1983 Jul; 16(1):77-83. PubMed ID: 6882626 [TBL] [Abstract][Full Text] [Related]
27. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease. Sandborn WJ Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205 [TBL] [Abstract][Full Text] [Related]
28. Absorption of the oral bisphosphonate alendronate in osteoporotic patients with Crohn's disease. Cremers SC; van Hogezand R; Bänffer D; den Hartigh J; Vermeij P; Papapoulos SE; Hamdy NA Osteoporos Int; 2005 Dec; 16(12):1727-30. PubMed ID: 15959617 [TBL] [Abstract][Full Text] [Related]
29. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease. Breslin NP; Nash C; Hilsden RJ; Hershfield NB; Price LM; Meddings JB; Sutherland LR Am J Gastroenterol; 2001 Oct; 96(10):2934-8. PubMed ID: 11693329 [TBL] [Abstract][Full Text] [Related]
30. Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Bjarnason I; O'Morain C; Levi AJ; Peters TJ Gastroenterology; 1983 Aug; 85(2):318-22. PubMed ID: 6407889 [TBL] [Abstract][Full Text] [Related]
31. Increased permeability of macroscopically normal small bowel in Crohn's disease. Peeters M; Ghoos Y; Maes B; Hiele M; Geboes K; Vantrappen G; Rutgeerts P Dig Dis Sci; 1994 Oct; 39(10):2170-6. PubMed ID: 7924738 [TBL] [Abstract][Full Text] [Related]
32. Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial. Israeli E; Goldin E; Fishman S; Konikoff F; Lavy A; Chowers Y; Melzer E; Lahat A; Mahamid M; Shirin H; Nussinson E; Segol O; Ya'acov AB; Shabbat Y; Ilan Y Clin Exp Immunol; 2015 Aug; 181(2):362-72. PubMed ID: 25846055 [TBL] [Abstract][Full Text] [Related]
34. Increased urinary excretion of iohexol after enteral administration in patients with ileal Crohn's disease. A new test for disease activity. Halme L; Edgren J; von Smitten K; Linden H Acta Radiol; 1993 May; 34(3):237-41. PubMed ID: 8489835 [TBL] [Abstract][Full Text] [Related]
35. Esophagitis in an adolescent patient with Crohn's disease after changing treatment from prednisolone to budesonide. Weigand K; Wagner-Thiessen E; Stolte M Z Gastroenterol; 2004 Oct; 42(10):1179-81. PubMed ID: 15508059 [TBL] [Abstract][Full Text] [Related]
36. Enhanced absorption of macromolecules. A secondary factor in Crohn's disease. Malin M; Isolauri E; Pikkarainen P; Karikoski R; Isolauri J Dig Dis Sci; 1996 Jul; 41(7):1423-8. PubMed ID: 8689920 [TBL] [Abstract][Full Text] [Related]
37. Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease. Saverymuttu S; Hodgson HJ; Chadwick VS Gut; 1985 Oct; 26(10):994-8. PubMed ID: 3902590 [TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of the viscous, high-molecular-mass microbial carbohydrate fraction from faeces of healthy subjects and patients with Crohn's disease and the consequences for a therapeutic approach. Ruseler-van Embden JG; Van Lieshout LM; Binnema DJ; Hazenberg MP Clin Sci (Lond); 1998 Oct; 95(4):425-33. PubMed ID: 9748418 [TBL] [Abstract][Full Text] [Related]
39. Lack of effect of intravenous azathioprine on time to respond for steroid treated Crohn's disease. Carter MJ; Lobo AJ Gut; 2001 Mar; 48(3):295-6. PubMed ID: 11171815 [No Abstract] [Full Text] [Related]
40. Effect of inflammatory bowel disease on absorption and disposition of prednisolone. Milsap RL; George DE; Szefler SJ; Murray KA; Lebenthal E; Jusko WJ Dig Dis Sci; 1983 Feb; 28(2):161-8. PubMed ID: 6825536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]